Jean Belasco is an Oncology physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 86 publications with 5,047 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 Civic Center Blvd
Children'S Hospital Of Philadelphia - Hem/onc
Philadelphia, PA 191044319
Telephone
215-590-3535Registry record last updated 15 Apr 2013.
Clinical trials
- Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
Sponsor: Children's Hospital of Philadelphia
- Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Sponsor: Children's Hospital of Philadelphia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
66.5%Opioid Agonist29.3%Oxycodone Hcl43%Morphine Sulfate35%Morphine Sulfate Er22%Part D<11 patientsGabapentinoids22.8%Gabapentin61%Pregabalin40%Part D<11 patients+ 2 more classes in this area
Cardiovascular
15%ACE inhibitor7.8%Lisinopril100%Part D<11 patientsStatin7.2%Atorvastatin Calcium100%Part D<11 patientsMetabolism & gastrointestinal
10.2%Serotonin-3 Receptor Antagonist10.2%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus
American Journal of Roentgenology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jonathan Spergel, MD
Children's Hospital of Philadelphia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”